Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Joseph A. Lahorra, MD, is Staff Cardiothoracic Surgeon in the Cleveland Clinic Department of Thoracic and Cardiovascular Surgery. He is the Medical Director of the Cardiothoracic Surgery Program at Parma Community General Hospital and sees patients at Parma Community General Hospital, Fairview Hospital, and MetroHealth Medical Center.
Dr. Lahorra has a special interest in adult cardiothoracic surgery, including coronary artery bypass, aortic valve replacement, mitral valve repair and replacement and surgery of the lungs, esophagus and mediastinum.
Dr. Lahorra is certified by the American Board of Thoracic Surgery. He is a fellow of the American College of Surgeons, and a member of the Society of Thoracic Surgeons and the American College of Chest Physicians.
A Cleveland native, Dr. Lahorra graduated from Orange High School. He received his Bachelor of Arts at Tufts University where he graduated summa cum laude and was elected to Phi Beta Kappa. He received his medical degree from Johns Hopkins University School of Medicine, where he was inducted into the Alpha Omega Alpha Medical Honor Society. He completed his residency in general surgery at University Hospitals of Cleveland. As the Dudley P. Allen Surgical Scholar, he completed a research fellowship at Massachusetts General Hospital. He received his cardiothoracic surgical training at the University of Michigan. After completing his training in 1997, Dr. Lahorra joined the staff of the Cleveland Clinic Heart Center in 2000.
Aortic Valve Replacement, Mitral Valve Repair, Mitral Valve Replacement, Aortic Aneurysm Repair, Coronary Artery Bypass Surgery, Lung Resection, Thoracoscopic/Robotic Surgery, Surgery for Atrial Fibrillation, Surgery of the Mediastinum.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/16/2013, Dr. Lahorra has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.